Evolent Health - Class A Shares Share Price (NYSE: EVH)

Live

Last updated on August 21, 2025 at 1:29 AM IST

$₹

Check the interactive Evolent Health - Class A Shares Stock chart to analyse performance

Evolent Health - Class A Shares stock performance

as on August 21, 2025 at 1:29 AM IST

Today's Low:$8.77
Today's High:$9.02
$9.00
2.61%
Downside
Day's Volatility :2.77%
Upside
0.17%
52 Weeks Low:$7.06
52 Weeks High:$33.63
$9.00
21.56%
Downside
52 Weeks Volatility :79.01%
Upside
73.24%

Evolent Health - Class A Shares Stock Returns

Period	Evolent Health, Inc. - Class A Shares	Sector (Health Care)	Index (Russel 2000)
3 Months	12.5%	1.5%	0.0%
6 Months	-14.45%	-7.1%	0.0%
1 Year	-67.8%	-11.4%	0.0%
3 Years	-75.01%	2.9%	-9.6%

Evolent Health, Inc. - Class A Shares Key Stats

Check Evolent Health - Class A Shares key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$9.0
Open	$8.86
Today's High	$9.03
Today's Low	$8.765
Market Capitalization	$1.0B
Today's Volume	$13.8M
52 Week High	$33.63
52 Week Low	$7.06
Revenue TTM	$2.2B
EBITDA	$72.2M
Earnings Per Share (EPS)	$-1.6
Profit Margin	-5.94%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-11.04%

Stock Returns calculator for Evolent Health - Class A Shares Stock including INR - Dollar returns

The Evolent Health - Class A Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Evolent Health - Class A Shares investment value today

Current value as on today

₹36,089

Returns

₹63,911

(-63.91%)

Returns from Evolent Health - Class A Shares Stock

₹67,800 (-67.8%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Evolent Health - Class A Shares Stock

59%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Evolent Health - Class A Shares Stock from India on INDmoney has increased by 59% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Evolent Health, Inc. - Class A Shares

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
9.42%
Cadian Capital Management LP
9.31%
BlackRock Inc
7.96%
Durable Capital Partners LP
5.54%
Eventide Asset Management, LLC
5.24%
Engaged Capital LLC
5.05%

Analyst Recommendation on Evolent Health - Class A Shares Stock

Rating

Trend

Buy

89%Buy

10%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Evolent Health - Class A Shares(by analysts ranked 0 to 5 stars)

Evolent Health - Class A Shares Share Price Target

What analysts predicted

Upside of 70.09%

Target:

$15.31

Current:

$9.00

Evolent Health - Class A Shares share price target is $15.31, a slight Upside of 70.09% compared to current price of $9.00 as per analysts' prediction.

Evolent Health - Class A Shares Stock Insights

Price Movement
In the last 1 year, EVH stock has moved down by -67.8%
Decreasing Revenue
Revenue is down for the last 3 quarters, 646.54M → 444.32M (in $), with an average decrease of 16.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -64.61M → -51.09M (in $), with an average increase of 26.5% per quarter
EVH vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 75.4% return, outperforming this stock by 143.2%
EVH vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 92.5% return, outperforming this stock by 166.5%
Price to Sales
ForEVH every $1 of sales, investors are willing to pay $0.5, whereas for Doximity, Inc., the investors are paying $20.2 for every $1 of sales.

Evolent Health, Inc. - Class A Shares Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$846.4M	↑ 34.98%
Net Income	$-305.6M	↑ 480.31%
Net Profit Margin	-36.1%	↓ 27.7%

	FY20	Y/Y Change
Revenue	$924.6M	↑ 9.25%
Net Income	$-334.2M	↑ 9.38%
Net Profit Margin	-36.15%	↓ 0.05%

	FY21	Y/Y Change
Revenue	$908.0M	↓ 1.8%
Net Income	$-30.8M	↓ 90.78%
Net Profit Margin	-3.39%	↑ 32.76%

	FY22	Y/Y Change
Revenue	$1.4B	↑ 48.91%
Net Income	$-19.2M	↓ 37.78%
Net Profit Margin	-1.42%	↑ 1.97%

	FY23	Y/Y Change
Revenue	$2.0B	↑ 45.26%
Net Income	$-113.0M	↑ 489.86%
Net Profit Margin	-5.76%	↓ 4.34%

	FY24	Y/Y Change
Revenue	$2.6B	↑ 30.09%
Net Income	$-61.6M	↓ 45.49%
Net Profit Margin	-2.41%	↑ 3.35%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$639.7M	↑ 15.03%
Net Income	$-17.3M	↓ 48.28%
Net Profit Margin	-2.7%	↑ 3.31%

	Q2 FY24	Q/Q Change
Revenue	$647.1M	↑ 1.17%
Net Income	$1.6M	↓ 109.24%
Net Profit Margin	0.25%	↑ 2.95%

	Q3 FY24	Q/Q Change
Revenue	$621.4M	↓ 3.98%
Net Income	$-23.1M	↓ 1549.69%
Net Profit Margin	-3.72%	↓ 3.97%

	Q4 FY24	Q/Q Change
Revenue	$646.5M	↑ 4.05%
Net Income	$-22.8M	↓ 1.45%
Net Profit Margin	-3.53%	↑ 0.19%

	Q1 FY25	Q/Q Change
Revenue	$483.6M	↓ 25.19%
Net Income	$-64.6M	↑ 183.39%
Net Profit Margin	-13.36%	↓ 9.83%

	Q2 FY25	Q/Q Change
Revenue	$444.3M	↓ 8.13%
Net Income	$-51.1M	↓ 20.94%
Net Profit Margin	-11.5%	↑ 1.86%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$333.3M	↑ 11.39%

	FY20	Y/Y Change
Profit	$228.1M	↓ 31.58%

	FY21	Y/Y Change
Profit	$250.4M	↑ 9.8%

	FY22	Y/Y Change
Profit	$316.6M	↑ 26.43%

	FY23	Y/Y Change
Profit	$460.5M	↑ 45.45%

	FY24	Y/Y Change
Profit	$367.4M	↓ 20.22%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$74.6M	↓ 26.59%

	Q2 FY24	Q/Q Change
Profit	$76.7M	↑ 2.77%

	Q3 FY24	Q/Q Change
Profit	$80.7M	↑ 5.24%

	Q4 FY24	Q/Q Change
Profit	$75.7M	↓ 6.17%

	Q1 FY25	Q/Q Change
Profit	$102.5M	↑ 35.34%

	Q2 FY25	Q/Q Change
Profit	$77.2M	↓ 24.62%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-42.6M	↑ 106.5%
Investing Cash Flow	$-181.6M	↑ 13.26%
Financing Cash Flow	$-35.5M	↓ 112.97%

	FY20	Y/Y Change
Operating Cash Flow	$-16.2M	↓ 61.95%
Investing Cash Flow	$261.1M	↓ 243.74%
Financing Cash Flow	$-11.9M	↓ 66.63%

	FY21	Y/Y Change
Operating Cash Flow	$38.7M	↓ 338.81%
Investing Cash Flow	$-15.8M	↓ 106.05%
Financing Cash Flow	$-29.5M	↑ 149.1%

	FY22	Y/Y Change
Operating Cash Flow	$-11.6M	↓ 129.82%
Investing Cash Flow	$-259.1M	↑ 1541.42%
Financing Cash Flow	$131.5M	↓ 545.18%

	FY23	Y/Y Change
Operating Cash Flow	$142.6M	↓ 1334.16%
Investing Cash Flow	$-415.5M	↑ 60.37%
Financing Cash Flow	$281.3M	↑ 113.88%

	FY24	Y/Y Change
Operating Cash Flow	$18.8M	↓ 86.84%
Investing Cash Flow	$-62.9M	↓ 84.86%
Financing Cash Flow	$-565.0K	↓ 100.2%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$4.9M	↓ 94.51%
Investing Cash Flow	$-9.7M	↑ 60.81%
Financing Cash Flow	$14.9M	↓ 117.64%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$21.4M	↑ 336.28%
Investing Cash Flow	$-13.5M	↑ 39.14%
Financing Cash Flow	$-103.4M	↓ 794.67%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$18.7M	↓ 12.83%
Investing Cash Flow	$-19.7M	↑ 45.7%
Financing Cash Flow	$-9.0M	↓ 91.29%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-26.2M	↓ 240.5%
Investing Cash Flow	$-19.9M	↑ 1.02%
Financing Cash Flow	$96.9M	↓ 1176.18%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$4.6M	↓ 117.4%
Investing Cash Flow	$-13.1M	↓ 34.31%
Financing Cash Flow	$107.9M	↑ 11.26%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-30.3M	↓ 764.49%
Investing Cash Flow	$-60.5M	↑ 362.32%
Financing Cash Flow	$-8.9M	↓ 108.28%

Evolent Health - Class A Shares Technicals Summary

Sell

Neutral

Buy

Evolent Health - Class A Shares is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Evolent Health, Inc. - Class A Shares Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Evolent Health, Inc. - Class A Shares	-7.79%	-14.45%	-67.8%	-75.01%	-32.74%
Tempus Ai	25.89%	-14.79%	24.39%	81.44%	81.44%
Doximity, Inc.	5.49%	-17.11%	75.43%	94.37%	19.92%
Ge Healthcare Technologies Inc.	-0.26%	-20.06%	-11.88%	22.28%	22.28%
Veeva Systems Inc.	1.15%	24.01%	46.75%	32.76%	6.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Evolent Health, Inc. - Class A Shares	712.02	NA	-1.37	0.23	-0.11	0.0	NA	7.73
Tempus Ai	30.86	30.86	NA	-0.78	-0.98	-0.12	NA	1.78
Doximity, Inc.	56.35	56.35	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	14.99	14.99	3.42	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	59.58	59.58	1.52	6.45	0.14	0.07	NA	38.11

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Evolent Health, Inc. - Class A Shares	Buy	$1.0B	-32.74%	712.02	-5.94%
Tempus Ai	NA	$11.5B	81.44%	30.86	-20.98%
Doximity, Inc.	Hold	$12.3B	19.92%	56.35	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.4B	22.28%	14.99	11.22%
Veeva Systems Inc.	Buy	$45.9B	6.47%	59.58	27.34%

About Evolent Health, Inc. - Class A Shares

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Organization	Evolent Health - Class A Shares
Employees	4500
CEO	Mr. Seth Barrie Blackley
Industry	Miscellaneous Commercial Services

Key Management of Evolent Health, Inc. - Class A Shares

Name	Title
Mr. Seth Barrie Blackley	Co-Founder, CEO & Director
Mr. Dan McCarthy	President
Mr. John Paul Johnson	Chief Financial Officer
Ms. Emily Rafferty	Chief Operating Officer
Mr. Jonathan David Weinberg J.D.	Chief Legal Officer, General Counsel & Secretary
Mr. Aammaad Shams	Chief Accounting Officer
Mr. Robert Cruz	Chief Technology Officer
Ms. Jessica White	Chief Information Officer
Mr. Seth R. Frank	Vice President of Investor Relations
Ms. Katie DiPerna Cook	Chief People Officer

Important FAQs about investing in EVH Stock from India :

What is Evolent Health - Class A Shares share price today?

Evolent Health - Class A Shares share price today is $9.00 as on August 21, 2025 at 1:29 AM IST. Evolent Health - Class A Shares share today touched a day high of $9.02 and a low of $8.77.

What is the 52 week high and 52 week low for Evolent Health - Class A Shares share?

Evolent Health - Class A Shares share touched a 52 week high of $33.63 and a 52 week low of $7.06. Evolent Health - Class A Shares stock price today i.e. August 21, 2025 at 1:29 AM IST is trending at $9.00, lower by 73.24% versus the 52 week high.

How to invest in Evolent Health - Class A Shares Stock (EVH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evolent Health - Class A Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evolent Health - Class A Shares Shares that will get you 0.1667 shares as per Evolent Health - Class A Shares share price of $9.00 per share as on August 21, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Evolent Health - Class A Shares Stock (EVH) from India?

Indian investors can start investing in Evolent Health - Class A Shares (EVH) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Evolent Health - Class A Shares stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Evolent Health - Class A Shares share’s latest price of $9.00 as on August 21, 2025 at 1:29 AM IST, you will get 1.1111 shares of Evolent Health - Class A Shares. Learn more about fractional shares .

What are the returns that Evolent Health - Class A Shares has given to Indian investors in the last 5 years?

Evolent Health - Class A Shares stock has given -32.74% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?